Stromal cell expression of components of matrix-degrading protease systems in human cancer

Enzyme and Protein

Volumn 49, Issue 1-3, 1996, Pages 163-173

  Hewitt, Robert ^a   Dano, Keld ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Invasion; Proteases; Stroma

Indexed keywords

PROTEINASE;

CANCER INVASION; CELL DEGENERATION; CELL INFILTRATION; EXTRACELLULAR MATRIX; HUMAN; REVIEW; STROMA CELL;

EID: 0029894671     PISSN: 10196773     EISSN: None     Source Type: Journal    
DOI: 10.1159/000468623     Document Type: Review

References (89)

1. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44:139-266.
2. Blasi F, Vassalli JD, Danø K: Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitors. J Cell Biol 1987;104:801-840.
3. Liotta LA, Steeg PS, Stetler-Stevenson GW: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336.
4. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993:4:41971250.
5. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993:73: 161-195.
6. Dan0 K, Behrendt N, Briinner N, Ellis V, Ploug M, Pyke C: The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994;8:189-203.
7. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 1990;68:1-19.
8. Stetler-Stevenson WG: Progelatinase A activation during tumour cell invasion. Invasion Metastasis 1995;14: 259-268.
9. Pei D, Majmudra G, Weiss SJ: Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 1994:29:255849-255855.
10. Mast AE, Enghild JJ, Nagase H, Suzuki K, Pizzo SV, Salvesen G: Kinetics and physiological relevance of their inactivation of ai-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72 kD gelatinase/type IV collagenase), and -3 (stromelysin). J Biol Chem 1991;266:15810-15816.
11. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ: The role of plasminogen activators ion the regulation of connective tissue metalloproteinases. Ann NY Acad Sei 1992:667:1-12.
12. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, DeVos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-24.
13. Bugge TH. Flick MJ, Daugherty CC, Degen JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Gene Dev 1995:9:794-807.
14. Bugge TH, Suh TT, Flick MJ, Daugherty CC, R0mer J, Solberg H, Ellis V, Dan0 K, Degen JL: The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 1995;270:16886-16894.
15. Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Dan0 K, Carmeliet P, Collen D, Degen JL: Urokinase-type plasminogen activator contributes to fibrin clearance by receptor-dependent and receptor-independent pathways. Submitted.
16. R0mer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound healing in plasminogen-deficient mice. Submitted.
17. Dan0K, Gr0ndahl-Hansen J, Eriksen J, Schnack-Nielsen B, R0merJ, Pyke C: The receptor for urokinase plasminogen activator. Stromal cell involvement in extracellular proteolysis during cancer invasion; in Barrett AJ, Bond J (eds): Proteolysis and Protein Turnover. London, Portland Press, 1993, pp 239-245.
18. Gr0ndahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR, Dano K: Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 1991;138: 111-117.
19. Pyke C, Kristensen P, Ralfkifer E, Gr0ndahl-Hansen J, Eriksen J, Blasi F, Dan0 K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991;138:1059-1067.
20. Tan K, Powe DO, Gray T, Turner DR, Hewitt RE: Regional variations of urokinase-type plasminogen activator in human colorectal cancer: A quantitative study by image analysis. Int J Cancer 1995:60:308-314.
21. Pyke C, Salo S. Ralfkiaer E, R0mer J, Dan0 K, Tryggvason K: Laminin-5 is a marker of invading cancer cells in some human carcinomas and is co-expressed with the receptor for urokinase plasminogen activator in hud ding cancer cells in colon adenocarcinomas. Cancer Res 1995:55:4132-4139.
22. Pyke C, Ralfkizer E. R0nne E, H0yer-Hansen G, Kirkeby G, Dan0 K: Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 1994:24:131-138.
23. Ohtani H, Pyke C, Dan0 K, Nagura H: Expression of urokinase receptor in various stromal cell populations in human colon cancer: Immunoelectron microscopical analysis. Int J Cancer 1995:62:691-696.
24. Pyke C, Kristensen P. Ralfkier E, Erikson J, Dan0 K: Messenger RNA for plasminogen activator inhibitor type-1 is present in endothelial cells in malignant colorectal tumors in man. Cancer Res 1991:51:4067-4071.
25. Kristensen P, Pyke C, Lund LR, Andreasen PA, Dan0 K: Plasminogen activator inhibitor type 1 in Lewis lung carcinoma. Histochemistry 1990;93:559-566.
26. Jänicke F, Schmitt M, Graeff H: Clinical relevance of the urokinase-type and tissue-type plasminogen activators and their type 1 inhibitor in breast cancer. Semin Thromb Hemost 1991:17:303-312.
27. Gr0ndahl-Hansen J, Christensen U, Rosenquist C, Briinner N. Mouridsen HT, Dan0 K. Blichert-Toft M: High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993:53:2513-2521.
28. Pedersen H. Gr0ndahl-Hansen J, Francis D, 0sterlind K, Hansen HH. Dan0 K. Brünner N: Urokinase and plasminogen activator type 1 in pulmonary adenocarcinoma. Cancer Res 1994:54:120-123.
29. Nielsen BS. Sehested M, Timshel S, Pyke C, Dan0 K: Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest, in press.
30. Pyke C: Histological investigation of human metastasizing tumors for components of the plasminogen activation system: PhD thesis. University of Copenhagen 1994, pp 1-30.
31. Pyke C, Gram N, Ralfkier E, R0nne E. H0yer-Hansen G, Brünner N. Dan0 K: The receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 1993:53:1911-1915.
32. Bianchi E, Cohen RL. Thor AT, Todd RH. Mizukami IF, Lawrence DA, Ljung BM, Shuman MA. Smith HS: The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 1994:54:861-866.
33. Reilly D, Christensen L, Duch M, Nolan N, Duffy MJ. Andreasen PA: Type-1 plasminogen activator inhibitor in human breast carcinomas. Int J Cancer 1992:50:208-214.
34. Sappino AP, Belin D, Huarte J, Hirschel-Scholz S, Saurai JH, Vassalli JD: Differential protease expression by cutaneous squamous and basal cell carcinomas. J Clin Invest I991;88:1073-1079.
35. de Vries JT. Quax PHA, Denijn M. Verrijp KM, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ. Muijen GNP: Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 1994:144:70-81.
36. Gress TM, Muller-Pillasch F, Lerch MM. Friess H, Buchler M, Adler G: Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995:62:407-413.
37. Polette M, Clavel C. Cockett M. de Bentzmann SG, Murphy G. Birembaut P: Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 1995:13:31-37.
38. Okada A, Bellocq JP, Rouyer N. Chenard MR Rio MC. Chambon P. Basset P: Membrane-type matrix metalloproteinase gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Nail Acad Sei USA 1995:92:2730-2734.
39. Ohtari Y, Okazaki I. Arai M. Kameyama K. Wada N, Maruyama K, Yoshino K. Kitajima M. Hosodo Y, Tsuchiya M: Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 1994:29:391-397.
40. Gray ST. Yun K, Motoori T, Kuvs YM: Interstitial collagenase gene expression in colonie neoplasia. Am J Pathol 1993:143:663-671.
41. Hewitt RE, Leach IH, Powe DG. Clark IM, Cawston TE, Turner DR: Distribution of collagenase and tissue inhibitor of metalloproteinases in colorectal tumours. Int J Cancer 1991 ;49:666-672.
42. Gallegos NC, Smales C. Savage FJ, Hembry RM, Boulos PB: The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 1995:4:21-29.
43. Gray ST, Wilkins RJ, Yun K: Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 1992:141:301-306.
44. Muller D. Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio M. Eber M. Methlin G. Chambon P, Basset P: Increased stromelysin-3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 1993:53:165-169.
45. Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P: Detection of mRNAs encoding collagenase I and stromelysin-2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 1991:11:76-83.
46. Huang CC, Blitzer A, Abramson M: Collagenase in human head and neck tumors and rat tumors and fibroblasts in monolayer cultures. Ann Otol Rhinol Laryngol 1986:95:158-161.
47. Wolf C, Chenard MP, Durand de Grossouvre P, Bellocq JP, Chambon P, Basset P: Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 1992':99:870-872.
48. Bauer EA, Gordon JM, Reddick ME, Eisen AZ: Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol 1977:69:363-367.
49. Childers JW, Hernandez AD, Kim JH, Stricklin GP: Immunolocalization of collagenase inhibition in normal skin and basal cell carcinoma. J Am Acad Dermatol 1987;17:1025-1032.
50. Pyke C, Ralfkiaer E, Tryggvason K, Dan0 K: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-365.
51. Poulsom R, Pignatelle M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L, Stamp GW: Stromal expression of 72-kD type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-396.
52. Boag AH, Young ID: Increased expression of the 72-kD type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am J Pathol 1994;144:585-591.
53. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F: Levels of matrix proteinases in bladder correlate with tumor grade and invasion. Cancer Res 1993:53:5365-5369.
54. Pyke C, Ralfkier E, Huhtala P, Hurskainen T, Dan0 K, Tryggvason K: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992;532: 1336-1341.
55. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67:1126-1131.
56. Polette M, Gilbert N, Stas I, Nawrocki B, Noel A, Remade A, Stetler-Stevenson WG, Birembaut P, Foidart M: Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch 1994;424:641-645.
57. Autio-Harmainen H, Karttunen T, Hurskainen T, Hoytya M, Kauppila A, Tryggvason K: Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 1993;69: 312-321.
58. Miyajima Y, Nakano R, Morimatsu M: Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 1995;104:678-684.
59. Poulsom R, Hanby AM, Pignatelle M, Jeffery RE, Longcroft JM, Rogers L, Stamp GW: Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 1993:46:429136.
60. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG: Increased expression of the Mr 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res 1991:51:439-444.
61. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dan0 K: 92kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer;1996:65,57-62.
62. McDonnell S, Navre M, Coffey RJ Jr, Matrisian LM: Expression and localization of the matrix metalloproteinase pump-1 in human gastric and colon carcinomas. Mol Carcinog 1991:4:527-533.
63. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT: Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991:117:144-150.
64. Newell KJ, Witty JP, Rodgers WH, Matrisian LM: Expression and localization of matrix-degradation metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994:10:199-206.
65. Noël A, Santavicca M, Stoll I, L'Hoir C, Staub A, Murphy G, Rio M, Basset P: Identification of structural determinants controlling human and mouse stromelysin-3 protelytic activities. J Biol Chem 1995:270:22866-22872.
66. Basset P, Bellocq JR Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer ÖL, Chehard MP, Rio MC, Chambon P: A novel metalloproteinase gene specificaly expressed in stromal cells of breast carcinomas. Nature 1990:348:699-704.
67. Rouyer N, Wolf C, Chenard MP, Rio MC, Chambon P, Bellocq JP, Basset P: Stromelysin-3 gene expression in human cancer: An overview. Invasion Metastasis 1995; 14:269-275.
68. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Belocq JP, Chambon P, Basset P: Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Nail Acad Sei USA 1993;90:1843-1847.
69. Nomura H, Sato H, Seiki M, Mai M, Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995:55:3263-3266.
70. Polette M, Clavel C, Birembaut P, De Clerck YA: Localization by in situ hybridization of mRNAs encoding stromelysin-3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol Res Pract 1993:189:1052-1057.
71. Polette M, Clavel C, Cockett M, Girod de Bentzmann S, Murphy G, Birembaut P: Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 1993:13:31-37.
72. Hoyhtya M, Frieman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG, Liotta LA, Liang CM: Immunohistochemical localization of matrix metalloproteinase-2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 1994;56:500-505.
73. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kD type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 1995:270:5331-5338.
74. Byrne JA, Tomasetto C, Rouyer N, Bellocq J-P, Rio M-C, Basset P: The tissue inhibitor of metalloproteinases3 gene in breast carcinoma: Identification of multiple polyadenylation sites and a stromal pattern of expression. Mol Med 1995:1:418-427.
75. Ellis V, Pyke C, Eriksen J, Solberg H, Dan0 K: The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sei 1992;667:13-31.
76. Lefebvre O, Wolf C, Limacher JM, Hutin P, Wendung C. LeMeur M. Basset P, Rio MC: The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Bio! 3992:119: 997-1002.
77. Lund LR, R0mer J, Thomasset N, Solberg H, Pyke C, Bissell MJ. Dan0 K, Werb Z: Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development, in press.
78. Kristensen P, Eriksen J, Blasi F, Dan0 K: Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J Cell Biol 1991:115:1763-1771.
79. Larsson L-I, Skriver L, Nielsen LS, Gr0ndahl-Hansen J, Kristensen P, Dan0 K: Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 1984;98:894-903.
80. Kristensen P, Eriksen J, Dan0 K: Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 1991:39:341-349.
81. R0mer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dan0 K: The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994:102:519-522.
82. Gr0ndahl-Hansen J, Lund LR, Ralfkiaer E, Ottevanger V, Dan0 K: Urokinase- and tissue-type plasminogen activators in keratinocytes during wound re-epithelialization in vivo. J Invest Dermatol 1988:90:790-795.
83. R0mer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter T, Dan0 K, Kristensen P: Differential expression of urokinase-type plasminogen activator and its type-2 inhibitor during healing of mouse skin wounds. J Invest Dermatol 1991:97:803-811.
84. Saarial-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993:92:2858-2866.
85. Saarial-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994:94:79-88.
86. Basset P, Wolf C, Chambon P: Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: A review. Breast Cancer Res Treat 1993:24:185-193.
87. Dvorak HF: Tumors: Wounds that do not heal. N Engl J Med 1986:315:1650-1659.
88. Andersson WAD, Kissane JM: Pathology, ed. 9. St Louis, Mosby, 1990.
89. Cotran RS, Kumar V, Robbins LS: Pathologic Basis of Disease, ed 4. Philadelphia, Saunders, 1989.